Pharmacokinetic and Pharmacodynamic Studies of Efficacy, Tolerability and Safety of Higher Dosage Rifapentine for Treatment of Tuberculosis.

Trial Profile

Pharmacokinetic and Pharmacodynamic Studies of Efficacy, Tolerability and Safety of Higher Dosage Rifapentine for Treatment of Tuberculosis.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Aug 2012

At a glance

  • Drugs Rifapentine (Primary) ; Rifampicin
  • Indications Tuberculosis
  • Focus Biomarker; Pharmacogenomic; Pharmacokinetics
  • Most Recent Events

    • 16 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Jul 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 16 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top